23 1 Vascular risk factors for depression and apathy 28. Burton RL, O’Connell ME, Morgan DG. Cognitive and Neuropsychiatric Correlates of Functional Impairment Across the Continuum of No Cognitive Impairment to Dementia. Arch Clin Neuropsychol. 2018;33(7):795-807. doi:10.1093/ARCLIN/ ACX112 29. Tsai CF, Hwang WS, Lee JJ, et al. Predictors of caregiver burden in aged caregivers of demented older patients. BMC Geriatr. 2021;21(1). doi:10.1186/S12877-02102007-1 30. Martinez-Martin P, Rodriguez-Blazquez C, Forjaz MJ, et al. Neuropsychiatric symptoms and caregiver’s burden in Parkinson’s disease. Parkinsonism Relat Disord. 2015;21(6):629-634. doi:10.1016/J. PARKRELDIS.2015.03.024 31. Eurelings LSM, van Dalen JW, ter Riet G, et al. Apathy and depressive symptoms in older people and incident myocardial infarction, stroke, and mortality: a systematic review and meta-analysis of individual participant data. Clin Epidemiol. 2018;10:363-379. doi:10.2147/CLEP. S150915 32. Van Dalen JW, Van Wanrooij LL, Moll Van Charante EP, Brayne C, Van Gool WA, Richard E. Association of Apathy With Risk of Incident Dementia: A Systematic Review and Meta-analysis. JAMA psychiatry. 2018;75(10):1012-1021. doi:10.1001/ JAMAPSYCHIATRY.2018.1877 33. Clarke DE, Ko JY, Kuhl EA, van Reekum R, Salvador R, Marin RS. Are the available apathy measures reliable and valid? A review of the psychometric evidence. J Psychosom Res. 2011;70(1):73-97. doi:10.1016/J.JPSYCHORES.2010.01.012 34. Guercio BJ, Donovan NJ, Munro CE, et al. The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment. J Alzheimers Dis. 2015;47(2):421-432. doi:10.3233/JAD150146 35. Robert P, Lanctôt KL, Agüera-Ortiz L, et al. Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group. Eur Psychiatry. 2018;54:71-76. doi:10.1016/J. EURPSY.2018.07.008 36. Brodaty H, Altendorf A, Withall A, Sachdev P. Do people become more apathetic as they grow older? A longitudinal study in healthy individuals. Int psychogeriatrics. 2010;22(3):426-436. doi:10.1017/ S1041610209991335 37. Manera V, Abrahams S, Ag L, et al. Recommendations for the Nonpharmacological Treatment of Apathy in Brain Disorders A R T I C L E I N F O. Am J Geriatr Psychiatry. 2020;28:410-420. doi:10.1016/j.jagp.2019.07.014 38. Ruthirakuhan MT, Herrmann N, Abraham EH, Chan S, Lanctôt KL. Pharmacological interventions for apathy in Alzheimer’s disease. Cochrane database Syst Rev. 2018;5(5). doi:10.1002/14651858. CD012197.PUB2 39. Seppi K, Ray Chaudhuri K, Coelho M, et al. Update on treatments for nonmotor symptoms of Parkinson’s disease-an evidence-based medicine review. Mov Disord. 2019;34(2):180-198. doi:10.1002/ MDS.27602 40. Kos C, van Tol MJ, Marsman JBC, Knegtering H, Aleman A. Neural correlates of apathy in patients with neurodegenerative disorders, acquired brain injury, and psychiatric disorders. Neurosci Biobehav Rev. 2016;69:381-401. doi:10.1016/J. NEUBIOREV.2016.08.012
RkJQdWJsaXNoZXIy MjY0ODMw